CLINICAL_TRIALS
trial_result
· 2020-08-11
Clinical Trial Update: Greater Occipital Nerve Block With Bupivacaine for Acute Migraine [Phase 3]
Summary
A Phase 3 clinical trial evaluating greater occipital nerve block with bupivacaine for acute migraine has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Montefiore Medical Center | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2020-08-11